Growth Metrics

Dexcom (DXCM) EBT Margin (2010 - 2026)

Dexcom (DXCM) reported EBT Margin of 22.61% for Q1 2026, up 772.0% year-over-year from 2.59% in Q1 2025, and down 16.41% on a QoQ basis from 27.05% in Q4 2025.

Dexcom (DXCM) has 17 years of EBT Margin data on file, last reported at 22.61% in Q1 2026.

  • Quarterly EBT Margin rose 772.0% year-over-year to 22.61% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 24.98% (up 736.0% YoY) and the FY2025 annual result came in at 23.35%, up 577.0% from the prior year.
  • EBT Margin fell to 22.61% in Q1 2026 per DXCM's latest filing, from 27.05% in the prior quarter.
  • Across five years, EBT Margin topped out at 29.13% in Q3 2025 and bottomed at 5.74% in Q1 2022.
  • The 5-year median for EBT Margin is 18.7% (2024), against an average of 18.34%.
  • The widest annual swing landed in 2022, when EBT Margin surged 1542 bps; it then sank 681 bps in 2024.
  • Tracing DXCM's EBT Margin over 5 years: stood at 16.34% in 2022, then jumped by 46 bps to 23.8% in 2023, then slipped by 20 bps to 18.98% in 2024, then soared by 43 bps to 27.05% in 2025, then fell by 16 bps to 22.61% in 2026.
  • Per Business Quant, the three latest DXCM EBT Margin figures stand at 22.61% (Q1 2026), 27.05% (Q4 2025), and 29.13% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 12.98%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 14.12%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 15.57%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 22.33%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 27.84%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 4.87%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 22.61%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 9.84%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 19.17%
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 14.44%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 22.61%
Dec 31, 2025 27.05%
Sep 30, 2025 29.13%
Jun 30, 2025 20.84%
Mar 31, 2025 14.89%
Dec 31, 2024 18.98%
Sep 30, 2024 17.84%
Jun 30, 2024 18.70%
Mar 31, 2024 14.39%
Dec 31, 2023 23.80%
Sep 30, 2023 24.66%
Jun 30, 2023 18.28%
Mar 31, 2023 8.70%
Dec 31, 2022 16.34%
Sep 30, 2022 19.00%
Jun 30, 2022 10.82%
Mar 31, 2022 5.74%
Dec 31, 2021 0.92%
Sep 30, 2021 17.23%
Jun 30, 2021 16.32%
Mar 31, 2021 8.18%
Dec 31, 2020 27.10%
Sep 30, 2020 14.99%
Jun 30, 2020 10.23%
Mar 31, 2020 5.53%
Dec 31, 2019 20.38%
Sep 30, 2019 11.56%
Jun 30, 2019 -2.76%
Mar 31, 2019 -9.48%
Dec 31, 2018 -52.34%
Sep 30, 2018 16.80%
Jun 30, 2018 12.21%
Mar 31, 2018 -13.02%
Dec 31, 2017 3.89%
Sep 30, 2017 -1.35%
Jun 30, 2017 -8.44%
Mar 31, 2017 -28.32%
Dec 31, 2016 -4.09%
Sep 30, 2016 -12.52%
Jun 30, 2016 -14.64%
Mar 31, 2016 -16.52%
Dec 31, 2015 1.22%
Sep 30, 2015 -40.79%
Jun 30, 2015 -3.97%
Mar 31, 2015 -17.72%
Dec 31, 2014 1.62%
Sep 30, 2014 -7.54%
Jun 30, 2014 -10.31%
Mar 31, 2014 -26.54%
Dec 31, 2013 -5.03%
Sep 30, 2013 -13.99%
Jun 30, 2013 -28.45%
Mar 31, 2013 -37.50%
Dec 31, 2012 -25.53%
Sep 30, 2012 -74.89%
Jun 30, 2012 -62.55%
Mar 31, 2012 -76.62%
Dec 31, 2011 -54.49%
Sep 30, 2011 -72.56%
Jun 30, 2011 -34.43%
Mar 31, 2011 -83.45%
Dec 31, 2010 -62.86%
Sep 30, 2010 -112.19%
Jun 30, 2010 -97.08%